Cardiovascular risk factors and the risk of Parkinson's disease

European Journal of Clinical Nutrition

Volumn 69, Issue 6, 2015, Pages 729-733

  Vikdahl, M ^a   Backman L ^a   Johansson, I ^a   Forsgren, L ^a   Haglin, L ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST TO HEIGHT RATIO; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; MOTOR ACTIVITY; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SEX DIFFERENCE; SWEDEN;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; MOTOR ACTIVITY; OVERWEIGHT; PARKINSON DISEASE; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; SWEDEN; TRIGLYCERIDES; WAIST-HEIGHT RATIO;

EID: 84930474213     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2014.259     Document Type: Article

References (27)

1. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, et al. Vascular contributions to cognitive impairment and dementia: a statement for health care professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672-2713
2. Kaffashian S, Dugravor A, Elbaz A, Shipley MJ, Sabia S, Kivimäki M, et al. Predicting cognitive decline: a dementia risk score vs the Framingham vascular risk scores. Neurology 2013; 80: 1300-1306
3. Aarsland D, Kvaløy JT, Andersen K, Larsen JP, Tang MX, Lolk A, et al. The effect of age of onset of PD on risk of dementia. J Neurol 2007; 254: 38-45
4. Linder J, Stenlund H, Forsgren L. Incidence of Parkinsons disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010; 25: 341-348
5. Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, et al. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 2007; 64: 990-997
6. Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J. Body mass index and the risk of Parkinson disease. Neurology 2006; 67: 1955-1959
7. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70: 1972-1979
8. Qiu C, Hu G, Kivipelto M, Marder KS, Nelson LM, Rocca WA, et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011; 57: 1094-1100
9. De Lau LM, Koudstaal PJ, Hofman A, Breteler MB. Serum cholesterol levels and the risk of Parkinsons disease. Am J Epidemiol 2006; 164: 998-1002
10. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H. Dietary fats, cholesterol and iron as risk factors for Parkinsons disease. Parkinsonism Relat Disord 2009; 15: 47-52
11. Scigliano G, Musicco M, Soliveri P, Piccolo I, Ronchetti G, Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 2006; 37: 1184-1188
12. Savica R, Grossardt BR, Ahlskog JE, Rocca WA. Metabolic markers or conditions preceding Parkinson's disease: a case-control study. Mov Disord 2012; 27: 974-979
13. Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson Disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 2005; 62: 378-382
14. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752
15. Hallmans G, Agren A, Johansson G, Johansson A, Stegmayr B, Jansson JH, et al. Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort-evaluation of risk factors and their interactions. Scand J Public Health Suppl 2003; 61: 18-24
16. Norberg M, Blomstedt Y, Lönnberg G, Nyström L, Stenlund H, Wall S, et al. Community participation and sustainability-evidence over 25 years in the Västerbotten Intervention Programme. Glob Health Action 2012; 5: 1-9
17. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinsons disease with [18F] dopaPET. J Neurol Neurosurg Psychiatry 1998; 64: 314-319
18. Simon KC, Chen H, Schwarzschild M, Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007; 69: 1688-1695
19. Abbott RD, Ross GW, White LR, Nelson JS, Masaki KH, Tanner CM, et al. Midlife adiposity and the future risk of Parkinsons disease. Neurology 2002; 59: 1051-1057
20. Ragonese P, DAmelio M, Callari G, Di Benedetto N, Palmeri B, Mazzola MA, et al. Body mass index does not change before Parkinsons disease onset. Eur J Neurol 2008; 15: 965-968
21. Hernán MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A. Cigarette smoking and the incidence of Parkinsons disease in two prospective studies. Ann Neurol 2001; 50: 780-786
22. Håglin LM, Törnkvist B, Bäckman LO. High serum phosphate and triglyceride levels in smoking women and men with CVD risk and type 2 diabetes. Diabetol Metab Syndr 2014; 6: 39
23. Vlajinac H, Sipetic S, Marinkovic J, Ratkov I, Maksimovic J, Dzoljic E, et al. The stressful life events and Parkinsons disease: a case-control study. Stress Health 2013; 29: 50-55
24. Sasco AJ, Paffenbarger RS Jr, Gendre I, Wing AL. The role of physical exercise in the occurrence of Parkinsons disease. Arch Neurol 1992; 49: 360-365
25. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Physical activity and the risk of Parkinsons disease. Neurology 2005; 64: 664-669
26. Thacker EL, Chen H, Patel AV, McCullough ML, Calle EE, Thun MJ, et al. Recreational physical activity and risk of Parkinsons disease. Mov Disord 2008; 23: 69-74
27. Tsekouras YE, Magkos F, Kellas Y, Basioukas KN, Kavouras SA, Sidossis LS. High-intensity interval aerobic training reduces hepatic very low-density lipoprotein-Triglyceride secretion rate in men. Am J Physiol Endocrinol Metab 2008; 295: E851-E858